News

The third edition of the conference “The best way to predict the future is to create it” will be held on the 28th of May!

The Kulski Foundation for Polish-American Relations in cooperation with the Medical Research Agency is honored to invite you to the third edition of the conference “The best way to predict the future is to create it” which will take place on the 28th of May 2020. The event, due to the current coronavirus pandemic, will be organized in a virtual formula.

During the upcoming edition of the conference titled “Post-COVID world. Chances and challenges for the healthcare sector ”, invited guests will discuss key challenges ahead of the international community in the era of the COVID-19 virus pandemic. The invited experts will also elaborate on the possible scenarios to efficiently mitigate the effects of the crisis.

Access to the transmission of the conference will be available only for registered participants. The registration form is available at: https://forms.gle/j6b7KUWDAgJTT8Mt6

 

The conference will be held under the official patronage of the Ministry of Health and the Ministry of Development.

Vision Group is the organizational partner of the event.

 

CONFERENCE AGENDA

 

11:45              EVENT OPENING

                       

OPENING SPEECHES

 

  • Małgorzata Bogusz, President of Kulski Foundation
  • Radosław Sierpiński, President of Medical Research Agency

 

SEGMENT I: COVID-19: THREAT OR CHANCE FOR HEALTHCARE SYSTEM IN POLAND?
(LANGUAGE – POLISH)

 

Moderator:

  • Bartosz Kwiatek, Polsat News

 

Keynote speech:

  • prof. Marcin Czech, Business School, Warsaw University of Technology; Head of the Department of Pharmacoeconomics, Institute of Mother and Child; Undersecretary of State, Ministry of Health in years 2017-2019
  • Marek Kowalski, Chairman, Federation of Polish Entrepreneurs 

 

12:15              DISCUSSION PANEL I: COVID-19 PANDEMIC – SCENARIO FOR THE POLISH HEALTHCARE SECTOR. WHERE ARE WE NOW AND WHERE ARE WE HEADING?

 

Speakers:

  1. Olga Semeniuk, Undersecretary of State, Ministry of Development
  2. prof. Zbigniew Gaciong, Rector-Elect, Medical University of Warsaw
  3. prof. Jarosław Pinkas, Chief Sanitary Inspector
  4. dr n. med. Grzegorz Czelej, Polish Parliament
  5. dr Aurelia Ostrowska, Director, Military Medical Service Department, Ministry of National Defence
  6. Irena Rej, President, „FARMACJA POLSKA” Chamber of Commerce
  7. Tomasz Latos, Chairman, Health Committee of Sejm
  8. Bernard Waśko, Vice-President for Medical Affairs, National Health Fund
  9. Bartłomiej Chmielowiec, Commissioner for Patients’ Rights

 

 

13:15              DISCUSSION PANEL II: DRUGS & MEDICAL DEVICES – DRUG SAFETY OF POLAND AND ACCESS TO INNOVATIVE TECHNOLOGIES – INCLUDING R&D

 

Keynote speech:

  • Maciej Miłkowski, Undersecretary of State, Ministry of Health

 

Speakers:

  1. prof. Paweł Krawczyk, Laboratory for Immunology and Genetics, Department of Pneumology, Oncology and Allergology, Medical University of Lublin
  2. dr Małgorzata Gałązka-Sobotka, Deputy Chairman, Council of the National Health Fund
  3. prof. Leszek Czupryniak, Head of the Department of Diabetology and Internal Medicine, Medical University of Warsaw
  4. dr Roman Topór-Mądry, President, Agency for Health Technology Assessment and Tariff System
  5. Piotr Najbuk, Public & Government Affairs Director, AstraZeneca Pharma Poland
  6. Radosław Sierpiński, President, Medical Research Agency
  7. prof. dr hab. Piotr Ponikowski, Head of Heart Diseases Department and Clinic of Cardiac Diseases, Wroclaw Medical University
  8. Barbara Dziuk, Chairwoman, Parliamentary Team for Rare Diseases

 

14:15                 DISCUSSION PANEL III: DIGITIZATION AND R&D PROGRAMS IN HEALTHCARE – PUBLIC-PRIVATE PARTNERSHIP DURING A PANDEMIC OF COVID- 19

 

Keynote speech:

  • Agnieszka Kister, Director, Center of Healthcare Information Systems

 

Speakers:

  1. Anna Gembicka, Secretary of State, Ministry of Development Funds and Regional Policy
  2. Wojciech Szefke, President of the Board, Technomed
  3. prof. Artur Mamcarz, Chief of the 3rd Department of Internal Medicine and Cardiology, Medical University of Warsaw
  4. Jakub Berezowski, Vice-President for Research Funding, Medical Research Agency
  5. dr Anna Kowalczuk, Director, National Medicines Institute
  6. dr Paweł Grzesiowski, Department of Health Care and Medical Certification, Centre of Postgraduate Medical Education

 

 

SEGMENT II: COVID-19 IMPACT ON GLOBAL HEALTHCARE SYSTEM

(LANGUAGE – ENGLISH)

 

Moderator:

  • Bartosz Kwiatek, Polsat News

 

15:15              DISCUSSION PANEL I: CORONAVIRUS IMPACT ON GLOBAL HEALTHCARE ECOSYSTEM – NEW CHALLENGES & MAIN NEEDS

 

Opening speech:

  • George Handy, President of the Supervisory Board, Alliance for Innovation

 

Speakers:

  1. Jakub Berezowski, Vice-President for Research Funding, Medical Research Agency
  2. Krzysztof Wojciechowski, Polish-American Business Council
  3. dr Grzegorz Juszczyk, Director General, National Institute of Public Health – National Institute of Health
  4. dr Michał Gryz, Director, Department for Inspection of Medicinal Products and Medical Devices, Office for Registration of Medicinal Products, Medical Devices and Biocidal Product
  5. Hilary Stiss, Senior Manager, International Affairs at Biotechnology Innovation Organization
  6. prof. Waldemar Priebe,Professor of Medicinal Chemistry; Department of Experimental Therapeutics; Division of Cancer Medicine; The University of Texas MD Anderson Cancer Center
  7. dr Lindsay Davies, Chief Scientific Officer, NextCellPharma, Karolinska Institute
  8. Radu Rasinar, President – CEE region, AstraZeneca

 

16:15              DISCUSSION PANEL II: HOW HEALTHCARE SECTOR COULD FIGHT WITH CONSEQUENCES OF COVID-19? GLOBAL BEST PRACTICES AND POTENTIAL FOR JOINT ACTIONS.

 

Keynote speech:

  • kpt. dr n. med., Jacek Siewiera, Head of the Hyberbaric Medicine Clinical Department, Military Institute of Medicine

 

Speakers:

  1. Jakub Berezowski, Vice-President for Research Funding, Medical Research Agency
  2. Eric Stewart, President, The American-Central European Business Association
  3. Hilary Stiss, Senior Manager, International Affairs at Biotechnology Innovation Organization
  4. Paul Hatch, Senior Advisor, Dentons US DC Office
  5. Réka Szemerkényi, Senior Fellow, The Center for European Policy Analysis
  6. Jakub Baran, President of the Management Board, Polish Stem Cells Bank
  7. Joana Branco, Innovation Director, Biocant Park
  8. Grzegorz Mączyński, Advocate collaborated with Katarzyna Bondaryk Law Firm

 

17:15              CLOSING REMARKS